NCT03223376 2025-12-01
FRUTIGA
Hutchmed
Phase 3 Completed
Clinical Trials
9 trialsNCT03579784 2024-04-19
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
Seoul National University Hospital
Phase 2 Active not recruiting
NCT04286711 2020-02-27
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer
China Medical University, China
Phase 1/2 Unknown
NCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT03286244 2019-02-21
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer
AnewPharma
Phase 1 Unknown
NCT01136031 2015-05-20
TI-2ndAGC
Seoul National University Hospital
Phase 1/2 Completed
NCT01015339 2015-05-19
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Peking University
Phase 3 Unknown
NCT02072317 2014-02-26
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer
Fudan University
Phase 2 Unknown
NCT02038621 2014-01-16
GZH-001
The Second People's Hospital of Sichuan
Phase 2 Unknown